Production (Stage)
CytomX Therapeutics, Inc.
CTMX
$2.69
-$0.0597-2.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.61% | -14.43% | -14.28% | -8.72% | -13.88% |
| Total Receivables | -36.96% | -7.43% | 20.79% | -78.94% | 283.95% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 33.72% | 10.46% | 3.75% | -17.51% | -24.20% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -19.27% | -13.59% | -13.21% | -14.45% | -8.58% |
|
|
|||||
| Total Current Assets | -19.27% | -13.59% | -13.21% | -14.45% | -8.58% |
| Net Property, Plant & Equipment | -12.44% | -12.62% | -10.38% | -8.51% | -8.51% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -6.17% | -5.97% | -5.49% | -5.34% | -4.94% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.37% | -0.36% | 10.47% | -0.40% | -0.30% |
| Total Assets | -18.28% | -13.27% | -12.71% | -13.79% | -8.48% |
|
|
|||||
| Total Accounts Payable | -74.63% | -23.49% | 132.73% | -68.89% | 34.71% |
| Total Accrued Expenses | -14.48% | -26.31% | 22.92% | -4.22% | -19.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.88% | 2.88% | 2.88% | 2.90% | 2.94% |
| Total Finance Division Other Current Liabilities | -49.28% | -30.04% | -22.38% | 0.11% | -6.53% |
| Total Other Current Liabilities | -49.28% | -30.04% | -22.38% | 0.11% | -6.53% |
| Total Current Liabilities | -41.47% | -28.06% | -16.54% | -1.16% | -7.30% |
|
|
|||||
| Total Current Liabilities | -41.47% | -28.06% | -16.54% | -1.16% | -7.30% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -32.64% | -24.23% | -18.72% | -15.50% | -13.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -34.17% | -17.63% | -7.60% | -36.08% | -24.13% |
| Total Liabilities | -39.29% | -25.51% | -14.71% | -11.98% | -13.19% |
|
|
|||||
| Common Stock & APIC | 0.29% | 0.60% | 0.29% | 1.03% | 0.31% |
| Retained Earnings | 3.40% | 2.66% | 0.80% | -0.92% | 1.91% |
| Treasury Stock & Other | -103.70% | -32.50% | 1,100.00% | 60.00% | -110.53% |
| Total Common Equity | 5,593.20% | 98.06% | 24.90% | 1.43% | 33.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5,593.20% | 98.06% | 24.90% | 1.43% | 33.23% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5,593.20% | 98.06% | 24.90% | 1.43% | 33.23% |
|
|
|||||